Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3845 clinical trials
featured
Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

  • 128 views
  • 08 Nov, 2020
  • 1 location
European Low and Intermediate Risk Neuroblastoma Protocol

The European study, LINES 2009 (Low and Intermediate Risk Neuroblastoma European Study), groups together in a single protocol the treatment of all patients with "non high risk" neuroblastoma (NB), with stratification into two groups: low risk and intermediate risk. These two separate cohorts are included in one single protocol to …

  • 103 views
  • 23 Jan, 2021
  • 80 locations
A Phase IIIb Multicenter International Study to Evaluate the Efficacy Safety and Tolerability of EK-12 in Patients With RRMS

Multiple sclerosis is a chronic autoimmune, inflammatory neurological disease of the central nervous system. It is the most common disabling neurologic disease of young people. This study is

magnetic resonance imaging brain
rebif
ACTH
  • 29 views
  • 02 Aug, 2021
  • 1 location
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus

be initiated through the US and International Donor Registries. Eligible patients must be at least 18 years old and have SLE with progressive kidney, lung, heart, or central nervous system

immunosuppressive agents
oral cyclophosphamide
nephritis
prednisone
corticosteroids
  • 34 views
  • 07 Nov, 2020
  • 1 location
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

The purpose of this study is to determine if using Avonex in combination with Zocor is a safe and effective therapy for subjects with relapsing remitting multiple sclerosis.

betaseron
avonex
interferon
relapsing multiple sclerosis
rebif
  • 19 views
  • 07 Nov, 2020
  • 1 location
Safety and Efficacy of Esmketamine Versus Dexmedetomidine

A comparative study on the safety and efficacy of esmketamine versus Dexmedetomidine during drug induced sleep endoscopy in children with positional obstructive sleep apnea: A consort-prospective, randomized, controlled clinical trial

  • 0 views
  • 15 May, 2021
  • 1 location
Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment

Vascular cognitive impairment (VCI) is a broad dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to vascular dementia (VaD), referred to as significant cognitive impairment and decline in function status. In this three-year project, we aim to evaluate the effects of biochemical data, early …

  • 0 views
  • 23 Jan, 2021
  • 1 location
Effects of Keppra on Thinking Emotions and Balance in Elderly Healthy Volunteers

Epilepsy is a common disorder with an incidence of about 6 per 1000. The incidence progressively increases above age 50. By age 75, the incidence is two to three fold compared with any age group. Unfortunately, older individuals are especially at risk to incur significant side effects to anti-epileptic drugs. …

keppra
antiepileptics
neuropsychological test
anti-epileptic drug
seizure
  • 4108 views
  • 07 Nov, 2020
  • 1 location
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

There is very limited data on the use of arsenic trioxide in newly diagnosed patients with acute promyelocytic leukemia. The use of arsenic trioxide was limited to relapsed patients mainly because of the superior efficacy of ATRA as primary therapy for newly diagnosed APML. Though the early study by Niu …

arsenic
hepatic toxicity
remission
tretinoin
  • 76 views
  • 07 Nov, 2020
  • 8 locations
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

This study is a multi-site Phase Ib/II, 2-arm non-randomized clinical trial to determine the efficacy and tolerability of a response-adapted regimen combining ruxolitinib, dexamethasone, and etoposide as Frontline therapy for patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH) or as Salvage therapy for patients with relapsed/refractory HLH. Primary Objective To determine …

  • 0 views
  • 08 Aug, 2021
  • 2 locations